investig
safeti
practic
conduct
transthorac
fineneedl
aspir
tfna
gener
hospit
set
appli
tfna
procedur
patient
hospit
communityacquir
pneumonia
cap
within
h
admiss
also
preliminari
assess
made
potenti
valu
ad
tfna
convent
method
diagnost
microbiolog
tfna
easi
perform
caus
littl
discomfort
seriou
advers
event
observ
spite
ongo
antimicrobi
treatment
like
aetiolog
diagnosi
establish
patient
tfna
may
provid
import
addit
inform
aetiolog
cap
main
aim
pilot
studi
investig
safeti
practic
conduct
transthorac
fineneedl
aspir
tfna
reach
aetiolog
diagnosi
communityacquir
pneumonia
cap
gener
hospit
set
also
preliminari
assess
made
diagnost
valu
ad
tfna
convent
method
clinic
microbiolog
conduct
tfna
fluoroscop
guidanc
cap
patient
mean
age
year
rang
year
tfna
perform
steril
condit
use
local
anaesthesia
needl
stylet
remov
attach
syring
contain
ml
isoton
salin
fluoroscop
guidanc
needl
introduc
pulmonari
infiltr
four
millilitr
salin
inject
inflam
area
leav
approxim
ml
carrier
fluid
syring
neg
pressur
appli
needl
slowli
retract
chest
xray
imag
taken
inspir
expir
h
tfna
procedur
pend
pcr
examin
aspir
divid
two
aliquot
frozen
case
tfna
sampl
convent
microbiolog
examin
collect
within
h
hospit
admiss
tabl
pulmonari
aspir
examin
use
realtim
pcr
specif
region
posit
rna
gene
bacteria
pcr
product
sequenc
use
genet
analyz
appli
biosystem
foster
citi
ca
usa
sequenc
analys
sequenc
analysi
appli
biosystem
consensu
sequenc
compar
sequenc
genbank
databas
identif
use
ncbi
blast
diagnost
repertoir
includ
realtim
quantit
pcr
target
fumar
reductas
frdb
gene
haemophilu
influenza
outer
membran
protein
copb
gene
moraxella
catarrhali
describ
kai
et
al
detect
streptococcu
pneumonia
use
primer
target
pneumococc
genom
dna
amplifi
qantitect
sybr
green
pcr
assay
vwr
intern
ab
stockholm
sweden
perform
rotorgen
instrument
corbett
research
mortlak
sydney
australia
dilut
genom
dna
extract
pneumonia
ccug
catarrhali
ccug
h
influenza
ccug
cultur
collect
univers
gothenburg
sweden
use
posit
control
melt
curv
analys
perform
ensur
specif
amplifi
product
oropharyng
swab
examin
use
virusspecif
realtim
pcr
assay
base
taqman
technolog
valid
routin
diagnost
use
tfna
procedur
easi
perform
seriou
advers
event
two
patient
develop
minor
selflimit
pneumothorax
seven
patient
report
pinpoints
haemoptysi
definit
aetiolog
cap
establish
case
eight
case
tfna
alon
tabl
presumpt
aetiolog
includ
diagnosi
establish
patient
except
one
patient
posit
cultur
rrna
genetarget
pcr
pcrposit
aspir
identifi
use
realtim
pcr
method
studi
show
tfna
technic
feasibl
busi
gener
hospit
set
confirm
procedur
associ
mild
discomfort
although
care
followup
disclos
minim
clinic
insignific
pneumothorax
two
case
davidson
et
al
report
patient
prefer
tfna
transtrach
aspir
one
studi
tfna
consid
pain
venipunctur
larg
review
repres
total
tfna
procedur
found
overal
risk
pneumothorax
chest
drainag
requir
case
wherea
aetiolog
diagnosi
base
bacteri
cultur
like
suffer
hour
antibacteri
treatment
tfna
pcrbase
diagnost
may
rel
unaffect
studi
ruizgonzalez
et
al
aetiolog
diagnosi
cap
obtain
studi
group
use
convent
method
success
rate
increas
use
tfna
patient
treat
antibiot
admiss
pneumonia
detect
cultur
tfna
materi
patient
wherea
pcr
reveal
aetiolog
materi
case
small
studi
aetiolog
found
case
eight
case
sole
tfna
first
studi
aetiolog
cap
diagnost
procedur
routin
perform
late
h
admiss
fact
patient
receiv
antibiot
treatment
undergo
tfna
may
explain
aetiolog
rare
confirm
cultur
conclud
hospit
set
tfna
safe
practic
method
aetiolog
diagnosi
cap
studi
ongo
assess
whether
extens
use
tfna
substanti
improv
aetiolog
diagnosi
cap
result
specif
target
antimicrobi
treatment
hospit
